Article

Single-cell molecular profiling using ex vivo functional readouts fuels precision oncology in glioblastoma

2022-12-08

Abstract excerpt

<title>Abstract</title> <p>Background Functional profiling of freshly isolated glioblastoma cells is being evaluated as a next-generation method for precision oncology. While promising, its success largely depends on the method to evaluate treatment activity which requires sufficient resolution and specificity. Methods Here, we describe the ‘precision oncology by single-cell profiling using ex vivoreadouts of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 516a2a49-4497-5205-93c5-3427cc218e5e
DOI: 10.21203/rs.3.rs-2304487/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Single-cell molecular profiling using ex vivo functional readouts fuels precision oncology in glioblastomaDOI 10.21203/rs.3.rs-2304487/v1Read

Single-cell molecular profiling using ex vivo functional readouts fuels precision oncology in glioblastomaSemantic proximity Read

Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?Semantic proximity Read

Gliamimic: A Longitudinal, Multimodal in Vitro Platform for Evaluating Glioblastoma Treatment Response and Relapse in Patient-derived Organoids or SpheroidsSemantic proximity Read

Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere modelsSemantic proximity Read

Systematic functional drug testing in patient-derived models reveals ex vivo sensitivities associated with clinical outcome in rare solid tumorsSemantic proximity Read

Rapid Functional Drug Screening of Passage-Zero Patient Brain Tumor Tissues Ex Vivo: Results from a Clinical Feasibility StudySemantic proximity Read

Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response earlySemantic proximity Read

Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivitySemantic proximity Read

Quantitative single cell heterogeneity profiling of patient derived tumor initiating gliomaspheres reveals unique signatures of drug response and malignancySemantic proximity Read

Trellis Single-Cell Screening Reveals Stromal Regulation of Patient-Derived Organoid Drug ResponsesSemantic proximity Read

Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patientsSemantic proximity Read

Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in gliomaSemantic proximity Read